Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 1/2 4Phase 4 2Phase 2 2Phase EARLY_PHASE1 1Phase 3 1Phase 2/3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Dermatologic 2

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 16Pemetrexed 15Cisplatin 15Erlotinib Hydrochloride 13icotinib 8Propofol 7Gefitinib 7Gemcitabine 6Docetaxel 6endostar protein 5Saline Solution 5Paclitaxel 5Nivolumab 5Endostatins 5tislelizumab 4lorlatinib 4anlotinib 4Vinorelbine 4Sevoflurane 4Drug Therapy 4Afatinib 4pembrolizumab 3durvalumab 3atezolizumab 3Zoledronic Acid 3Radiotherapy 3Dexamethasone 3Acetaminophen 3trilaciclib 2pegfilgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Cryosurgery × Thoracic × Clear all
NCT06483009 2024-08-30

Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC

Shanghai Chest Hospital

Phase 4 Not yet recruiting
20 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02744664 2020-05-27

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Fuda Cancer Hospital, Guangzhou

Phase 4 Completed
60 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡